These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 8917212)

  • 21. Septal branch aneurysm during coronary computed tomography angiography: a cause of right bundle branch block?
    Shah RG; Shen M; Kirsch J
    Eur Heart J; 2009 Feb; 30(4):515. PubMed ID: 18820323
    [No Abstract]   [Full Text] [Related]  

  • 22. What are the sources of error in measuring and calculating cerebral metabolic rates with fluorine-18-fluorodeoxyglucose and PET?
    Alavi A; Smith R; Duncan D
    J Nucl Med; 1994 Sep; 35(9):1466-70. PubMed ID: 8071693
    [No Abstract]   [Full Text] [Related]  

  • 23. Is septal glucose metabolism altered in patients with left bundle branch block and ischemic cardiomyopathy?
    Thompson K; Saab G; Birnie D; Chow BJ; Ukkonen H; Ananthasubramaniam K; Dekemp RA; Garrard L; Ruddy TD; Dasilva JN; Beanlands RS
    J Nucl Med; 2006 Nov; 47(11):1763-8. PubMed ID: 17079808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Positron emission tomography in the diagnosis and management of coronary artery disease.
    Bratton NG
    J La State Med Soc; 1995 May; 147(5):193-6. PubMed ID: 7782672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Site of QRS notching in left bundle branch block depends on thickness of different walls of left ventricle.
    Mittal SR; Jain S; Mathur DK; Sharma S
    J Electrocardiol; 1998 Jul; 31(3):269-70. PubMed ID: 9682903
    [No Abstract]   [Full Text] [Related]  

  • 26. [Positron emission tomography: the prospects for studying myocardial metabolism in vivo].
    Ashmarin IIu
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(2):103-7. PubMed ID: 6391515
    [No Abstract]   [Full Text] [Related]  

  • 27. [Diagnosis using nuclear medicine of anterior descending artery stenosis in patients with left bundle branch block].
    Smanio PE; Martins LR; Tazima S; Meneghelo R; Thom A; Sousa JE
    Arq Bras Cardiol; 1995 Nov; 65(5):423-5. PubMed ID: 8729860
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thallium-201 uptake in lung cancer.
    Chin BB; Zukerberg BW; Buchpiguel C; Alavi A
    J Nucl Med; 1995 Aug; 36(8):1514-9. PubMed ID: 7629600
    [No Abstract]   [Full Text] [Related]  

  • 29. Positron-emission tomography: assessment of myocardial blood flow and metabolism.
    Schelbert HR
    Circulation; 1985 Nov; 72(5 Pt 2):IV122-33. PubMed ID: 3902283
    [No Abstract]   [Full Text] [Related]  

  • 30. Fluorine-18-fluorodeoxyglucose PET to determine regional cerebral glucose utilization: a re-examination.
    Schmidt KC; Lucignani G; Sokoloff L
    J Nucl Med; 1996 Feb; 37(2):394-9. PubMed ID: 8667082
    [No Abstract]   [Full Text] [Related]  

  • 31. Images in neuroscience. Neuroimaging, I.PET with [18F]fluorodeoxyglucose.
    Tamminga CA
    Am J Psychiatry; 1995 Oct; 152(10):1415. PubMed ID: 7573578
    [No Abstract]   [Full Text] [Related]  

  • 32. Cardiac clinical utility of fluorinated deoxyglucose.
    Bianco JA
    J Nucl Med; 1991 May; 32(5):892-4. PubMed ID: 2023004
    [No Abstract]   [Full Text] [Related]  

  • 33. Imaging metabolism and biochemistry--a new look at the heart.
    Schelbert HR; Phelps ME; Shine KI
    Am Heart J; 1983 Mar; 105(3):522-6. PubMed ID: 6600873
    [No Abstract]   [Full Text] [Related]  

  • 34. Features of positron emission tomography as a probe for myocardial chemistry.
    Schelbert HR
    Eur J Nucl Med; 1986; 12 Suppl():S2-10. PubMed ID: 3490372
    [No Abstract]   [Full Text] [Related]  

  • 35. Myocardial viability--what is the definition?
    Gropler RJ; Bergmann SR
    J Nucl Med; 1991 Jan; 32(1):10-2. PubMed ID: 1988611
    [No Abstract]   [Full Text] [Related]  

  • 36. Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure.
    Castro P; Winter JL; Verdejo H; Orellana P; Quintana JC; Greig D; Enríquez A; Sepúlveda L; Concepción R; Sepúlveda P; Rossel V; Chiong M; García L; Lavandero S
    J Heart Lung Transplant; 2012 Oct; 31(10):1096-101. PubMed ID: 22975099
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Myocardial viability studies using fluorine-18-FDG SPECT: a comparison with fluorine-18-FDG PET.
    Chen EQ; MacIntyre WJ; Go RT; Brunken RC; Saha GB; Wong CY; Neumann DR; Cook SA; Khandekar SP
    J Nucl Med; 1997 Apr; 38(4):582-6. PubMed ID: 9098206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Diagnosis of cancers by FDG-PET].
    Ichiya Y
    Fukuoka Igaku Zasshi; 1997 Jan; 88(1):7-10. PubMed ID: 9091463
    [No Abstract]   [Full Text] [Related]  

  • 39. Positron tomography and myocardial metabolism: an overview.
    Sobel BE
    Circulation; 1985 Nov; 72(5 Pt 2):IV22-30. PubMed ID: 3931935
    [No Abstract]   [Full Text] [Related]  

  • 40. Fluorodeoxyglucose (FDG) and tumour metabolism.
    Van Wyngaarden KE; Pauwels EK
    Nucl Med Commun; 1995 Dec; 16(12):987-9. PubMed ID: 8719978
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.